Skip to main content
Premium Trial:

Request an Annual Quote

Inforsense to Distribute Pharsight's Software in China

NEW YORK (GenomeWeb News) – Pharsight has signed up Inforsense to distribute its products in China through its subsidiary in Shanghai.
Under the agreement, Inforsense will market Pharsight’s software, which is used in pharmacokinetic and pharmacodynamic analysis, reporting, archiving, and data visualization. Inforsense will distribute the software in the Chinese pharmaceutical and biotech research and development market, and conduct sales and marketing, end-user training, and maintenance and support services.
The companies also have agreed to partner to develop translational research solutions for drug developers, and they may collaborate to use biomarkers in clinical PK/PD modeling.
"Bringing together our capabilities in genotypic and other molecular analysis with Pharsight's PK/PD tools and expertise is a major step towards making the goal of translational research a reality,” Inforsense Chief Scientific Officer Jonathan Sheldon said in a statement.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.